Skip to content

13F-HR/A filed by Tamarack Capital Management, LLC

Tamarack Capital Management, LLC filed this 13F-HR/A for the quarter ended 2013-09-30, filed 2013-11-18, with 32 holding rows worth $377,658,000.

Accession
0001095449-13-000123
Filed
2013-11-18
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2013

A holdings report, amendment of type restatement, 32 entries on the cover page, a total value of $377,658,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $377,659,000 with VALUE read as thousands by filing date, 13F file number 028-15086. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS600,000$100,806,000thousands by filing dateput
QUEST DIAGNOSTICS INC COM74834L100Stock375,000$23,171,000thousands by filing date
ALKERMES PLCG01767105SHS625,000$21,013,000thousands by filing date
PACIRA BIOSCIENCES INC COM695127100Stock375,000$18,028,000thousands by filing date
GREATBATCH INC39153L106COM410,000$13,952,000thousands by filing date
VIROPHARMA INC928241108COMMON STOCK350,000$13,741,000thousands by filing date
VOLCANO CORPORATION928645100COM544,050$13,030,000thousands by filing date
SPECTRANETICS CORP84760C107COM730,000$12,264,000thousands by filing date
ALLERGAN INC018490102COM125,000$11,306,000thousands by filing datecall
MEDASSETS INC584045108COM440,000$11,185,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR270,000$10,201,000thousands by filing datecall
Health Care Select Sector SPDR Fund81369Y209SHS200,000$10,118,000thousands by filing dateput
COVIDIEN PLCG2554F113SHS165,000$10,055,000thousands by filing date
ATRICURE INC04963C209COM900,000$9,882,000thousands by filing date
AUXILIUM PHARMACEUTICALS05334D107COMMON STOCK525,000$9,555,000thousands by filing date
VARIAN MED SYS INC92220P105COM125,000$9,341,000thousands by filing date
DEXCOM INC COM252131107Stock326,794$9,222,000thousands by filing date
NATUS MEDICAL INC639050103COM589,080$8,353,000thousands by filing date
CAREFUSION CORP14170T101COM225,000$8,303,000thousands by filing date
RTI BIOLOGICS INC74975N105COM2,200,000$8,228,000thousands by filing date
PERRIGO CO PLC F714290103COM66,000$8,143,000thousands by filing date
VOCERA COMMUNICATIONS INC92857F107COMMON STOCK425,000$7,905,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock112,200$7,812,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW40,000$3,966,000thousands by filing date
BRUKER CORP116794108COM175,000$3,614,000thousands by filing date
SOLTA MED INC83438K103COM1,500,000$3,105,000thousands by filing date
HEALTHSTREAM INC42222N103COM76,423$2,895,000thousands by filing date
CHEMED CORP NEW16359R103COM37,000$2,646,000thousands by filing date
CONMED CORP COM207410101Stock77,393$2,628,000thousands by filing date
GENTIVA HEALTH SERVICES37247A102COM157,525$1,897,000thousands by filing date
STANDARD BIOTOOLS INC34385P108COM43,974$965,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK25,000$329,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001095449-13-000120 superseded2013-11-07acceptance time not in the bulk data set
13F-HR/A 0001095449-13-000123this filing2013-11-18acceptance time not in the bulk data set